TheEdgeResearch
Home / Stocks / MAV

Pioneer Municipal High Income Advantage Fund, Inc. (MAV)

NYSE Financial Services Asset Management - Income
$8.08 ▲ +0.12%
Market Cap
$193.2M
Sector
Financial Services
Industry
Asset Management - Income
Beta
0.74
52-Wk Range
7.62-9.01
CEO
John Francis Cogan Jr.
Country
US
Currency
USD

Pioneer Municipal High Income Advantage Fund, Inc. operates in the Asset Management - Income industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $8.08, up 0.12% on the session, giving a market capitalisation of $193.2M. On trailing twelve-month figures it carries a trailing P/E of 109.93, a net margin of 33.1%. Its beta of 0.74 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
109.93
Price / Sales
36.44
Price / Book
0.91
EV / EBITDA
108.91
Gross margin
44.9%
Operating margin
33.1%
Net margin
33.1%
Return on equity
—
Debt / equity
0.00
Current ratio
7.74
Dividend yield
0.0%
Payout ratio
528.7%
Company profile
Exchange
New York Stock Exchange
Employees
0
IPO date
2003-10-23
Headquarters
Boston, MA, US
About Pioneer Municipal High Income Advantage Fund, Inc.

The Pioneer Municipal High Income Advantage Fund, Inc. operates as a closed-end mutual fund dedicated to fixed-income assets, managed by Pioneer Investment Management, Inc. This fund primarily allocates capital within the United States' fixed income markets, with a distinct focus on municipal bonds. Its performance is evaluated against two key benchmarks: the Barclays Capital High Yield Municipal Bond Index and the Barclays Capital Municipal Bond Index. Established in the U.S. on August 6, 2003, the fund was previously identified as Pioneer Municipal Advantage Trust.

Comparable companies

Pioneer Municipal High Income Advantage Fund, Inc. is most often compared with the following Financial Services names:

CBHIHITINSIIVHMHIMIONSLPHTPMFSABA
More research on MAV
MAV technical analysis MAV TheEdge Score Compare against peers
Open full interactive analysis & DCF →